SEC Filing Details

SEC Filing Details

Document Details

Form
DEFM14A
Filing Date
Aug 21, 2026
Document Date
Aug 21, 2026
Form Description
Definitive proxy statement relating to merger or acquisition
Filing Group
Mergers & Acquisitions
Company
Theravance Biopharma
Issuer
Theravance Biopharma, Inc.

©2019- Theravance Biopharma.  All rights reserved.  Terms of Use.  Global Privacy Notice.  Social Media Guidelines. US Supplemental Privacy Notice.

THERAVANCE BIOPHARMA®, THERAVANCE®, the Cross/Star logo and MEDICINES THAT MAKE A DIFFERENCE®, are registered trademarks, and TARGETING WHAT MATTERS MOST™ is a trademark of the Theravance Biopharma group of companies (in the U.S. and certain other countries). YUPELRI® is a registered trademark of Mylan Specialty L.P., a Viatris Company. Trademarks, trade names or service marks of other companies appearing on this website are the property of their respective owners.